102 related articles for article (PubMed ID: 28495138)
1. Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
Asmail A; Kesler A; Drory VE; Kolb H; Karni A
J Neuroimmunol; 2017 Jun; 307():47-52. PubMed ID: 28495138
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
[TBL] [Abstract][Full Text] [Related]
3. A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences.
Asmail A; Kesler A; Kolb H; Drory VE; Karni A
Int J Neurosci; 2019 Apr; 129(4):313-319. PubMed ID: 30260722
[TBL] [Abstract][Full Text] [Related]
4. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
Jordan B; Schilling S; Zierz S
J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
[No Abstract] [Full Text] [Related]
5. Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.
Boldingh MI; Maniaol A; Brunborg C; Dekker L; Lipka A; Niks EH; Verschuuren J; Tallaksen C
Muscle Nerve; 2017 Jun; 55(6):819-827. PubMed ID: 27641227
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
7. [Myasthenia gravis. Register of 190 cases in a single center].
Aguirre F; Villa AM
Medicina (B Aires); 2020; 80(1):10-16. PubMed ID: 32044736
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis patients with anti-MuSK antibodies.
Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
[TBL] [Abstract][Full Text] [Related]
11. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
13. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
14. Acquired myasthenia gravis in childhood.
Evoli A
Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
16. Serological and clinical features of patients with myasthenia gravis in north Indian population.
Suhail H; Subbiah V; Singh S; Behari M
Int J Neurosci; 2010 Feb; 120(2):115-9. PubMed ID: 20199203
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls.
Rodolico C; Parisi D; Portaro S; Biasini F; Sinicropi S; Ciranni A; Toscano A; Messina S; Musumeci O; Vita G; Girlanda P
J Neuromuscul Dis; 2016 Aug; 3(3):413-418. PubMed ID: 27854225
[TBL] [Abstract][Full Text] [Related]
19. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
[TBL] [Abstract][Full Text] [Related]
20. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG
J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
